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ABSTRACT 
 
TUNG T. NGUYEN:   
Craniofacial Variations in the Tricho-Dento-Osseus Syndrome 
(Under the direction of Dr. J Timothy Wright) 
 
Tricho-dento-osseous (TDO) syndrome is an autosomal dominant trait 
characterized by curly kinky hair at birth, enamel hypoplasia, taurodontism, thickening 
of cortical bones and variable expression of craniofacial morphology.  Genetic studies 
have identified a 4 bp deletion in the DLX3 gene that is associated with TDO; however, 
phenotypic characterization and classification of TDO remains unclear in the literature.  
This study compares the craniofacial variations between 53 TDO affected subjects and 
34 unaffected family members.  Standardized cephalograms were obtained and 
digitized.  Cephalometric measures were analyzed using a general linear model with 
family as a random effect.  Many of the craniofacial measurements in both groups 
showed marked variability.  TDO affected subjects showed smaller SNB, ANB angles, 
longer mandibular corpus length (GoGn) and shorter ramus height (p<0.05). 
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I  LITERATURE REVIEW 
 
 TRICHO-DENTO-OSSEOUS SYNDROME 
 
 Tricho-dento-osseous syndrome is an autosomal dominant disorder with complete 
penetrance characterized by abnormalities involving hair, bone and teeth.  It was first 
identified in 1966 by Robinson (1).  He presented 5 cases from a single pedigree in which all 
affected family members displayed enamel hypoplasia and curly kinky hair.  He showed an 
autosomal dominant inheritance pattern over four generations and suggested that this 
condition was distinct from amelogenesis imperfecta due to the association of both enamel 
hypoplasia and hair characteristics.  In 1970, Crawford reported a similar population of 
subjects exhibiting taurodontism in addition to enamel hypoplasia and curly hair (2).  It was 
not until 1971 that TDO was characterized as a distinct condition by Lichtenstein et al. (3).  
He traced six generations of an Irish-American family residing in the mountains of 
Washington County Virginia, along the Holston River.  The kindred displayed kinky hair at 
birth, enamel hypoplasia, taurodontism and sclerotic bone inherited in an autosomal 
dominant pattern.  He reported that affected subjects had increased susceptibility to dental 
caries, gingival abscess, brittle nails, increased cortical bone density of the skull and altered 
craniofacial morphology including dolichocephaly, frontal bossing and a square jaw.   
 More cases of TDO were identified in the following years, yet the nature of the 
genetic defect responsible for TDO remained unknown.  In 1973, Jorgenson and Warson re-
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examined Lichtenstein’s TDO population and suggested that the three dental phenotypes, 
taurodontism, enamel hypoplasia and dental impactions, observed in TDO were a direct 
result of defects in dental epithelia (4).  He noted that taurodontism is due to a defect in 
Hertwig’s epithelial root sheath.  The sheath consists of an inner and outer dental epithelium 
which surrounds the base of the developing crown and grows inward to produce multiple 
roots.  Failure of the epithelium to invaginate at the correct horizontal level results in 
taurodontism.  He cited Weinmann’s study (5) which showed defects in the inner dental 
epithelium during the formative stage resulted in enamel hypoplasia, while defects in the 
maturation stage resulted in enamel hypocalcification.  He suggested that defective reduced 
enamel epithelia, a derivative of dental epithelium, were unable to disorganize the tissue 
overlying the crown, an event that is necessary for the eruption process.  Based on these 
observations, he proposed that a single gene mutation in dental epithelia was responsible for 
TDO. 
 Melnick, argued that it was mesenchymal tissues, not epithelia, that were responsible 
for all the reported features of TDO (6).  He examined extracted teeth from affected subjects 
under light and scanning electron microscopy and discovered peri-radicular sheath, 
membranes that surrounds the open apices and extended part way up the root, containing 
collagen fibers.  He cited the works of Kollar (7, 8), who demonstrated that dental papilla 
was responsible for induction of radicular development, and Croissant (9), who showed that 
odontoblasts play a critical role in the initiation of enamel matrix.  He noted other 
predominant TDO features such as osteosclerosis of the skull and involvement of hair and 
nail were mesenchymal in nature.  Together with his microscopy findings, it lent support to a 
mesenchymal involvement. 
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 In 1983, another kindred with TDO was discovered along the Holston River, in 
Tennessee, by Quattromani and Shapiro (10).  In addition to the fuzzy kinky hair and enamel 
hypoplasia, they found affected individuals also displayed sclerotic and thickened calverium 
and long bones that showed subtle undertubulation but no sclerosis.  In light of the variable 
phenotypic expression and close proximity between the kindreds, Shapiro et al  hypothesized 
that differences in the phenotypic subtypes were due to distinct genetic entities and argued 
for the classification of TDO subtypes, TDO-I and TDO-II (11).  TDO Type I exhibits the 
typical kinky curly hair, enamel hypoplasia, delayed teeth eruption, thickened 
chondrocranium, but normal calvarial density and thickness.  TDO Type II displayed sparse 
kinky hair that was easily detachable, nail changes, precocious tooth eruption and thickening 
and sclerosis of the calveria.  This created controversy among researchers as to whether the 
variance in the TDO phenotype was a result of genetic heterogeneity or variable expression 
of a single gene mutation.  This subclassification of TDO was influenced in part by the works 
of Rivas et al (12).  Using polymorphic protein markers, they performed a linkage analysis 
on the Virginia kindred and suggested possible linkage between the TDO-I locus and the 
ABO, GC and Kell blood group loci.  However, a later study by Hart et al showed that this 
linkage was incorrect (13).   
 The TDO controversy continued in the 1980’s as many authors questioned whether 
TDO was a distinct syndrome or merely a subdivision of amelogenesis imperfecta 
hypomaturation- hypoplasia (AIHHT).  In 1990, Crawford and Alfred (14) performed a 
critical review of the TDO literature and concluded that TDO syndrome was different from 
AIHHT with taurodontism but suggest that the two disorders may represent variable clinical 
expression of a common gene mutation. They supported Witkop’s proposal (15) that the 
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minimal diagnostic criteria for TDO should include enamel hypoplasia, posterior teeth with 
taurodontism, autosomal dominant inheritance pattern, and tightly curly hair at birth and/or 
radiographic evidence of bone sclerosis.  They concluded that nail and bony defects were not 
always present and that many early cases of TDO were mistakenly reported as AIHHT.  
Seow believed that TDO and AIHHT with taurodontism are distinct entities and suggested 
that the two could be delineated by dental phenotype (16).  She observed that all reported 
cases of TDO exhibited severe taurodontism of the mandibular first permanent molars and 
suggested that it be used as a criteria to diagnose TDO syndrome (17).  This would later be 
refuted by Wright et al who showed taurodontism of mandibular first molars was highly 
variable (13).   
 In 1997, Wright identified on three new TDO kindreds in Alamance County of 
Western North Carolina and established a link between one of North Carolina family and that 
of the Midwest TDO family reported by Melnick (6).  Their phenotypic analysis of this TDO 
population revealed marked variability in clinical characteristics (18).  Enamel hypoplasia 
and taurodontism showed full penetrance in affected individuals while hair and bone 
characteristics were variably expressed.  Kinky curly hair at birth was found in 85% of the 
affected population.  However, 55% was developed straight hair by childhood.  Wright 
proceeded to examine the hair follicles of TDO affected subjects under electron microscopy 
and found that hair shaft for TDO syndrome subjects were smaller and tended to have central 
shaft depression (19).  All TDO individuals had generalized thin and/or pitted enamel 
hypoplasia.  Taurodontism was present in all affected individual, but it did not always affect 
the first permanent molars and ranged from mild to severe.  Skeletal involvement was more 
prevalent in the North Carolina TDO population (97%) compared to unaffected family 
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members (30%).  Affected individuals showed a greater prevalence of obliterated diploe, lack 
of frontal sinus pneumatization and lack of mastoid pneumatization.  In 1996, Kula et al 
characterized craniofacial features of TDO syndrome in the North Carolina kindred (20).  
They reported that the affected individuals had significantly longer anterior cranial base 
length (SN), greater cranial base angle (BaSN), longer mandibular body length (GoPg) and a 
more obtuse gonial angle in TDO affected adults compared to unaffected adults.  They 
measured cortical bones of skulls on cephalograms and found that TDO affected individuals 
had thicker intramembranous bones, although it was unclear whether the thicker cortical 
bone was a product of increased bone deposition on the external surface or decreased bone 
resorption on the inner surfaces.  Islam et al reported similar findings in 2005 (21). They 
reported three new cases of TDO from a large family and saw an increase in bone density in 
long bone, increased thickness and density of skull bone especially skull base and mandibles 
that are in the “upper normal size limit” with increased trabeculation and bone density in 
TDO affected individuals.   Haldeman et al performed dual-energy x-ray absorptiometry 
(DEXA) scans at fours common standardized test regions.  They found a marked increase in 
bone mineral density of TDO affected subjects with no associated systemic pathology.  This 
increase in bone mineral density occurred in intramembranous as well as endochondral bone 
suggesting the role of DLX3 in bone formation and/or homeostasis of the appendicular 
skeleton (22). 
 The late 1990’s heralded the genotypic characterization of TDO. Hart et al evaluated 
the North Carolina families and using a genome-wide search strategy.  They obtained 
evidence for linkage of the TDO syndrome locus to a marker on chromosome 17q21 
(D17S791) (13).  However, there were hundreds of expressed sequences, including several 
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candidate genes that could account for the phenotypic traits of TDO, located in the interval at 
17q21.  Price et al. narrowed their search to two specific members of the Distal-Less 
homeobox gene family located in this region, DLX3 and DLX7.  They cloned and sequenced 
both genes and identified a 4 base pair deletion in human DLX3 which correlated with the 
TDO syndrome phenotype (23).  The 4 base pair deletion causes a frameshift mutation 
leading to the formation of a termination codon.  The resulting truncated protein can 
potentially still bind to DNA, but due to the intact homeodomain region, but is functionally 
altered.  While the DLX gene family has been shown to be important in tooth and bone 
development in the murine model, this was the first human study to show their importance in 
the development of hair, teeth and bones.  Price et al also evaluated the Virginia TDO 
kindred reported by Lichtenstein.  They found the same 4 base pair base deletion mutation 
previously reported in the North Carolina kindred (24).  Additionally, the affected Virginia 
TDO subjects had the same haplotype found in the affected North Carolina TDO subjects 
suggesting the DLX3 deletion mutation was inherited from a common ancestor.  They further 
suggested that the clinical variability observed in the Virginia and North Carolina families 
was not the result of genetic heterogeneity at the multiple loci, but reflected genetic 
heterogeneity at other epigenetic loci and/or contributing environmental factors. 
 In 1999, Price et al re-examined the association between TDO and amelogenesis 
imperfecta hypomaturation- hypoplasia type (AIHHT).  Armed with the knowledge that TDO 
is caused by a DLX3 mutation deletion, they performed mutational analysis and sequencing 
studies on a family with AIHHT.  Neither the affected nor unaffected AIHHT subjects 
possessed the 4 base pair DLX3 mutation present in the known TDO affected subjects.  The 
authors concluded that TDO and AIHHT were genetically distinct conditions (25).  In 2005, 
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Dong et al renewed the debate with their published study of an Australian “AIHHT” family 
(26).  The affected subjects all showed reduced enamel thickness and enlarge pulps.  No 
family members had curly hair and skull radiograph of affected individuals showed no 
evidence of bone sclerosis.  The authors excluded the diagnosis of TDO due to a lack of bone 
and hair involvement.  However, it is interesting to note that 55% of TDO affected subjects 
hairs straighten throughout childhood (18) and DEXA scans were not performed on the 
Australian members in the study to truly rule out bone involvement.  They identified a novel 
2 base pair CT deletion DLX3 mutation.  This new mutation was located within the 
homeodomain of DLX3 and produces an altered protein truncated by 88 amino acids at the 
COOH terminus compared the 32 amino acid truncation found in the TDO DLX3 mutation.  
The authors concluded that TDO and some forms of AIHHT are allelic and suggest that this 
new DLX3 mutation affects the formation of enamel and teeth, but lacks the defects of bone 
and hair.  Recently, Wright et al identified another group of TDO kindred in Switzerland 
with the same 2 base pair (c561_562delCT) deletion mutation.  All affected subjects had 
diminished hair shaft diameter and morphology similar to the c.571_574delGGGG DLX3 
deletion.  They all had reduced enamel thickness, although tooth size and severity of 
taurodontism were less severe compared to the 4G deletion mutation.  While the Switzerland 
family did not exhibit sclerotic bone on skull radiograph, they all displayed a slight increase 
in bone mineral density based on DEXA evaluation.  The authors conclude that this new 2 
base pair deletion causes attenuated phenotype of TDO syndrome and not AIHHT (27). 
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DLX 3 
 
 Dlx genes are vertebrates homologous to the Distal-Less (DII) gene originally 
characterized in Drosophila.  To date six DLX homedomain genes have been identified and 
organized into 3 pairs (DLX1/ DLX2) located on chromosome 2, DLX5/ DLX6 located on 
chromosome 7 and DLX3/ DLX7 located on chromosome 17q21) (28).  These homeodomain 
proteins act as transcription factors that regulate many developmental processes, ranging 
from organizing body segments to differentiation of individual tissues.  DLX genes are 
thought to regulate cell differentiation in the skeleton including bone, cartilage and tooth.  In 
the forebrain, DLX1, DLX2, DLX5 and DLX6 have overlapping spatial expression and a 
distinct temporal pattern of expression (29)   
 Unlike the other members of the DLX family, DLX3 is not expressed in central 
nervous system (30).  Early DLX3 expression is localized in specific areas of the first and 
second branchial arches including neural crest cells that will give rise to odontoblast and 
craniofacial structure.  Later in development, DLX3 is expressed in structures with epithelial 
mesenchymal interaction such as skin, hair follicles, otic and olfactory placodes, limb buds, 
placenta, tooth germs (29, 30, 31, 32).  Attempts at targeted deletion of the DLX3 gene in 
mouse result in embryonic death due to failure of the placenta to undergo proper 
morphogenesis (32).  
 In the skin, DLX3 is expressed in stratified epidermis and the matrix cells at the base 
of hair follicles and thought to play a key role in murine keratinocyte differentiation (33).  
Transcription of DLX3 is initiated in the suprabasal cells as they start their migration 
outwards and begin terminal differentiation.  In addition, transgenic over-expression of DLX3 
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in basal cell layer produces abnormal epidermal phenotype including cessation of cellular 
proliferation and premature differentiation of basal cell (31).  Morasso et al. outlined a 
possible pathway for the regulation of DLX3 in keratinocytes.  Using a series of in vitro 
experiments, they showed that bone morphogenic protein (BMP-2) induced DLX3 expression 
through phosphorylation of Smad1/ Smad4 proteins (34).  Recently, DLX3 was shown to be 
regulated by p63, a gene associated with ectodermal dysplasia (EDs) (35). 
 Robinson and Mahon first described DLX3 expression in the developing murine 
dentition in 1994 (29).  Using radioactive in situ hybridization, they localized DLX3 
expression to dental mesenchyme early in development.  A later study by Zhao et al (36) 
produced conflicting results.  They found DLX3 was expression in dental epithelium 
throughout tooth development and argued that Robinson’s radioactive in situ hybridization 
technique had lower cellular resolution.   They reported that DLX2 and DLX3 are the only 
DLX genes expressed in the lamina of molar and incisor primordial during embryonic stages 
that correlate to tooth initiation.  Citing a study by Mina and Kollar (37) which showed that 
tooth development is initiated by signals from dental epithelium, the authors suggest that 
DLX3 plays a role in tooth initiation.  Their study also showed DLX3 expression in the early 
cap and enamel late bell stage of tooth development.  Ghoul-Mazgar reported that DLX3 is 
expressed in differentiating ameloblast and down-regulated during odontoblast polarization 
suggesting a role in tooth morphogenesis (38).  This would be consistent with altered tooth 
morphology exhibited in TDO patients. 
 Identification of a DLX3 mutation in people with TDO revealed a link between bone 
development the DLX gene family (23).  DLX3 mutation in humans result in altered 
osteogenesis and increase in mineral density of bone matrix suggesting a role in 
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endochrondral ossification (22).  In vivo experiments in human and murine embryonic 
tissues showed that DLX3 protein expression varied specifically with terminal differentiation 
of ameloblast, odontoblast, osteoblast and chondoblasts (38).  The authors reported DLX3 
protein expression in chondrocytes in the prehypertrophic cartilage zone and differentiating 
osteoblasts of metaphyseal periosteum.  It is interesting to note that DLX3 protein expression 
correlated well temporally and spatially with Indian Hedgehog (Ihh), a gene associated with 
chondrogenesis and osteogenesis.  Hassan et al examined the regulatory role of DLX3 in 
osteoprogenitors cells (39).  They showed recruitment of DLX3 proteins to the osteocalcin 
(OC) promoter region during osteoblast differentiation.  DLX3 association with the OC 
promoter region decreased while Dlx5 recruitment increased during the mineralization stage 
of osteoblast differentiation.  Recently, Choi et al tested the effects of the DLX3 4 base pair 
mutation in preosteoblastic and multipotent mesenchymal cells (40).  The 4 bp deletion 
mutation produced mesenchymal differentiation to an osteoblastic lineage instead of a 
myoblastic lineage.  It also accelerated osteoprogenitor cells differentiation to osteoblast.  
 Much has been learned about the function and regulation of DLX3 in the past few 
years.  However, the early lethality of DLX3 knock-out in mouse limits our ability to study 
the role of DLX3 in late development.  TDO offers a unique genetic model to exam the role 
of DLX3 in craniofacial development.  The tissues affected by TDO (hair, teeth and bone) 
correlate with the known expression DLX3 in different tissues (hair matrix cells, dental 
epithelium, odontoblast, and neural crest cell).  By characterizing the phenotypic expression 
of TDO, we can continue to uncover the role of DLX3 in human craniofacial development.   
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II  INTRODUCTION 
 
 Tricho-dento-osseous syndrome (TDO) is an autosomal dominant disorder with 
complete penetrance characterized by abnormalities involving hair, teeth and bone (10).  
Early reports of TDO subject showed marked phenotypic variability of the tissues involved 
including changes in fingernails, enamel hypoplasia, taurodontism, doliocephaly, cranial 
sclerosis and mandibular prognathism (4).    
 The identification of a large group of TDO individuals in North Carolina led to the 
discovery of the molecular etiology of TDO (19).  Using a genome-wide search strategy, 
TDO was mapped to a locus on chromosome 17q21, a region known to contain members of 
the distal-less homeobox gene family including DLX3 and DLX7 (13).  Molecular analysis of 
individuals with TDO revealed a 4 bp deletion mutation of DLX3 (c.571_574delGGGG).  
This deletion produces a frame-shift mutation resulting in early termination of the DLX3 
protein (23).  A re-examination of the original Lichtenstein TDO population indicated that all 
affected members carry the same 4 bp DLX3 mutation suggesting that the phenotypic 
variations observed in TDO subjects are not the result of genetic heterogeneity at multiple 
loci, but reflect genetic heterogeneity at other epigenetic loci and/or contributing 
environmental factors. 
 DLX3 is a member of the homeobox gene family homologous to the Distal-Less (DII) 
gene of Drosophila.  DLX genes act as transcription factors that regulate many developmental 
processes, ranging from organizing body segments in Drosophila, to differentiation of 
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individual tissues including bone cartilage and tooth (29, 41).  Early DLX3 expression is 
localized in specific areas of the first and second branchial arches including neural crest cells 
that will give rise to odontoblast and craniofacial structures.  Later in development, DLX3 is 
expressed in structures with epithelial mesenchymal interaction such as skin, hair follicles, 
otic and olfactory placodes, limb buds, placenta, tooth germs (29, 31).   
 Attempts at targeted deletion of the DLX3 gene in mice result in embryonic death due 
to failure of the placenta to undergo proper morphogenesis (32) limiting our ability to study 
the role of the gene in later development.  TDO offers a unique genetic model to exam the 
role of DLX3 in craniofacial development.  The tissues observed to be affected by TDO (hair, 
teeth and bone) are associated with some of the tissues showing expression of DLX3 (hair 
matrix cells, dental epithelium, odontoblast, and neural crest cell).   
 Kula et al measured variations in craniofacial features between TDO and unaffected 
family members (20) They reported an increase in bone density and thickness of the 
chondrocranium and calveria, lack of pneumatization of the mastoids, frontal sinus and 
diploe, greater cranial base length and cranial base angle, longer mandibular body length and 
less obtuse gonial angle in TDO individuals.  However, this study had a limited sample size 
with TDO status determined by phenotypic traits rather genetic testing.  Affected individuals 
also had a marked increase in bone density in both endochondral and intramembranous bone 
formation with no associated systemic pathology suggesting an association between TDO 
syndrome and bone formation and homeostasis (22).  With the marked variations of bone 
craniofacial phenotype displayed by TDO affected subjects, studies that examine craniofacial 
morphology must be large enough that to rule out possible familial traits.  Our current study 
contains the largest sample of size of TDO affected and unaffected family members 
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evaluated to date and characterizes the craniofacial features of TDO syndrome to help 
elucidate the role of DLX3 in human craniofacial development. 
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III  MATERIALS AND METHODS 
 
Subjects 
 Eight families from a single kindred were identified for clinical and radiographic 
signs of TDO. The study was approved by the Biomedical Institutional Review board and 
informed consent was obtained from all participants.  DNA was extracted from peripheral 
blood samples using standard DNA isolation techniques (Qiagen, Valencia, CA).  DLX3 gene 
was sequenced using primers for all three exons and splice sites.  Amplicons were sequenced 
using ABI 770 and verified (24).  Subjects were screened for TDO by genetic testing for the 
mutations in the DLX3 gene.  Allocation of subjects to affected or unaffected TDO groups 
was done based on genetic results for DLX3 mutations.  The demographic characteristics of 
the TDO and unaffected family members are shown in Table 1. 
 
Cephalometric Analysis 
Cephalograms were taken at a standardized distance with a magnification of 12%.  
All subjects were positioned in natural head position.  Edentulous subjects were recorded 
without prostheses with their mandible in rest position.  Cephalograms were scanned and 
imported into Dolphin Imaging software version 9.0 (Chatworths, CA).  Digitization and 
cephalometric analysis were performed by one examiner (TN).  Fourteen linear and angular 
measurements were recorded (Figure 1 and Table 2).  Bilateral anatomic structures were 
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bisected.  Composite cephalograms were generated for the 53 TDO affected and 34 
unaffected subjects using the protocol described by Proffit et al (42).  Superimpositions were 
performed along the Sella-Nasion (S-N) line with registration at Sella (s) and the inferior 
border of the mandible with registration on Menton (Me) (Figure 2). 
 
Reliability of the Measurements 
 The intraclass correlation statistic was used to assess the reliability of the 
measurements using ten randomly selected cephalograms that were traced and digitized on 
three occasions over a two week intervals by the same observer. 
  
Statistical Analysis 
The influence of the presence of TDO on craniofacial cephalometric measures was 
assessed adjusting for the effect of age, gender, and edentulous status using a general linear 
model with age, sex, edentualism, and TDO status as main effects.  Family was considered a 
random effect.  Alternative covariance structures were examined to control for the expected 
correlation among subjects within the family unit.  Variance component was selected due to 
the non-convergence of the models when more complex covariance structures were used.  
Variance component divides the overall error variance into two components- variation 
between families and variation between subjects within families.  The model for each 
measure was fit with a random intercept for each family.  Significance level was set at 
P<0.05. 
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IV  RESULTS 
 
Intra-class correlation coefficient (ICC) ranged from 87% to 99.5% for the intra-
observer reliability.  Midface length (Co-A) had the lowest ICC of 87%.  All other variables 
had ICCs above 90% implying high intra-observer consistency for all other cephalometric 
measures.  
 Marked variation was observed in most of the cranial features measured in this study.  
Summary of the results after adjusting for age, gender and edentulous status is shown in 
Table 3 & 4.  Affected individuals varied from severe Class III appearances to moderate 
Class II with mandibular retrusion.  The average midface length (Co-A) was similar between 
the two groups, but average maxillary protrusion (SNA) was significantly less (P<0.001) in 
the affected group compared to the unaffected group.  Average ANB (p = 0.0018) was also 
smaller in the affected group.  Mandibular protrusion (SNB) was comparable between the 
two groups.  There was no statistical significant difference in cranial base length (N-Ba, S-N, 
S-Ba) or cranial base angle (Ba-S-N) between affected and unaffected subjects. 
 There was no statistically significant difference in total face height (N-Me), upper 
face height, (N-ANS) or lower face height (ANS-Me) between the TDO affected group and 
unaffected control.  Mandibular body length (Go-Gn) was significantly longer (p = 0.009) in 
the TDO affected individuals with a mean difference of 3.6mm when compared with the 
unaffected individuals.  Ramus height (Ar-Go) was significantly shorter (p = 0.05) in 
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affected individuals, however, there was no difference in gonial angle (Ar-Go-Me) between 
affected and unaffected individuals. 
Superimpositions of composite tracings representing the population samples of TDO 
affected and unaffected individuals are shown in Figure 2.  Superimposition performed at the 
cranial based showed that TDO affected group tended to have a more anterior positioned 
Nasion (N) and slightly posterior positioned Basion (Ba).  A point (A) and anterior nasal 
spine (ANS) was slightly retrusive in the TDO affected group when compared to the 
unaffected controls.  Superimposition of the composite tracing at the inferior border of the 
mandible showed that the TDO affected group had a longer mandibular body length and 
shorter ramus height.  In addition the condyles of the TDO group were positioned more 
inferior and posterior when compared the unaffected group. 
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V  DISCUSSION 
 
 Early reports of TDO in the literature noted variable craniofacial features including 
doliocephalic facial pattern, square jaw and mandibular prognathism (1, 3, 4).  However, 
these studies often had small sample size and relied on clinical signs for classification of 
TDO which may not be as accurate as genotypic classification.  In this study, we present the 
largest reported sample of TDO affected individuals confirmed for the DLX3 mutation by 
genetic testing. 
 Kula et al. (20) reported that TDO affected individuals had a more obtuse cranial 
flexure and increased cranial base length compared with unaffected individuals.  Shapiro et 
al. (11) also noted flattened cranial bases and dolichocephalic appearances, but no 
cephalometric values were reported.  We found no statistical significant difference in cranial 
base length or cranial base angle although our cranial base length means were comparable to 
those reported by Kula et al.  Our study also found no statistical significant difference in total 
face height, upper or lower face height.  While Kula reported no difference in face height, 
they noted that both groups tended to have a greater total and lower face height than 
standards.  While we did not compare individual face height values to Bolton and Behrent’s 
standards (43), our mean face height values for TDO affected and unaffected groups were 
similar to those published by Behrents (43) when matched for mean age of each group.  A 
possible explanation is that in clinical studies, subjects with drastic phenotypic traits are often 
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first identified and enrolled.  As more subjects are recruited and examined, a once dramatic 
trait could normalize to the mean especially with the level of phenotypic variance in 
craniofacial expression exhibited in TDO individuals. 
 The position of the maxilla in relation to the cranial base (SNA) was more retrusive in 
TDO affected individual compared to unaffected individuals, although there was no 
difference in maxillary unit length (Co-A) between the groups.  The composite 
superimposition (Figure 2) showed that TDO affected individuals tended to have a more 
anteriorly positioned nasion (N) and upper face rather than an absolute retrusion of the 
midface when compared to unaffected family members.  It is interesting to note that both 
groups showed slightly smaller maxillary length (Co-A) when compared to standards.  This 
coincides with early case reports citing maxillary deficiency in TDO subjects (1, 3, 16).  Kula 
et al. (20) reported no significant difference in SNA or CoA measurements in her study, but 
noted that 84% of the TDO affected and 80% of non-affected populations had smaller 
maxillas compared to Bolton standards.  Further studies are needed to determine if this slight 
maxillary retrusion found in both groups is due to a familial trait.  The Intraclass Correlation 
in our study was lowest (87%) for condylion (Co) which could explain why no significance 
difference in midface length was observed in between the groups. 
 Patients with TDO are often described as having prognathic mandibles (1, 3, 16).  
Our study showed no difference in mandibular protrusion (SNB), but due to a retrusive 
maxilla, the relative position of the mandible to the maxilla (ANB) appears more prognathic 
with a Class III appearance.  Whether this Class III skeletal pattern observed in TDO 
individuals is due to familial influences or mutation in the DLX3 gene remains to be 
determined and further studies are needed to test this.  TDO individuals had significantly 
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longer mandibular body length (Go-Gn), shorter ramus height (Ar-Go) with no difference in 
gonial angle (Ar-Go-Me).  A shorter ramus height can mask mandibular projection even with 
a significant increase in body length.  Previous studies by Robinson (1) and Lichtenstein (3) 
suggest that a more obtuse gonial angle is characteristic of TDO whereas the present study 
revealed a normal gonial angle.  These studies were descriptive in nature and had a high 
percentage of edentulous patients.  The edentulous mandible undergoes bone deposition at 
the inferior border of the corpus and resorption in the antegonial region giving the 
appearance of a more obtuse gonial angle (44).   
 Skeletal patterning in the vertebrate system is a complex process involving numerous 
molecular pathways, transcription factors and regulatory proteins.  DLX3 has been shown to 
a plays a role in osteogenesis and bone formation (38, 39).  While our study shows that TDO 
affected individuals display considerable phenotypic variation, there does appears to be an 
association between DLX3 mutation and craniofacial dysmorphology.  Future studies of 
DLX3 mutation and thorough phenotyping of TDO syndrome will help advance our 
understanding of craniofacial development and bone formation. 
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VI  CONCLUSIONS 
 
1.   TDO affects subjects display relatively retrusive maxilla (SNA) and decreased SNB 
compared to unaffected family members. 
2.   DLX3 gene mutation resulting in TDO syndrome is associated with a statistically 
significant increase in mandibular body length (Go-Gn). 
3. DLX3 gene mutation resulting in TDO syndrome is associated with a statistically 
significant decrease in ramus height (Ar-Go). 
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VII. TABLES 
 
Table 1.  Demographic Characteristics of the TDO Affected and Unaffected Groups 
  Mean Age Gender Edentulous 
TDO 31.7 Females = 25 26% 
n = 53 (5.0 - 79.3) Males = 28   
Unaffected 37.1 Females = 18 6% 
n = 34 (5.8 - 76.0) Males = 16   
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Table 2.  Cephalometric Measurements 
Linear measurements 
Cranial base (N-Ba) 
Anterior cranial base (S-N) 
Posterior cranial base (S-Ba) 
Total face height (N-Me) 
Upper face height (N-ANS) 
Lower face height (ANS-Me) 
Mandibular ramus height (Ar-Go) 
Maxillary unit length (Co-A) 
Mandibular unit length (Co-Gn) 
Mandibular body length (Go-Gn) 
 
Angular measurements 
Cranial base angle (Ba-S-N) 
Gonial angle (Ar-Go-Me) 
SNA 
SNB 
ANB 
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Table 3.   Mean Cephalometric Values and Standard Errors 
Variables TDO   Unaffected   
  TDO Mean SEM Unaffected Mean SEM 
SNA 78.84 0.45 81.50 0.53 
SNB 77.58 0.51 78.22 0.62 
ANB 1.27 0.39 3.29 0.3 
N-Ba 113.09 0.98 110.79 1.05 
S-N 75.96 0.67 75.01 0.7 
S-Ba 40.15 0.78 38.51 0.85 
Ba-S-N 129.42 0.58 128.72 0.81 
N-Me 122.15 1.71 122.88 1.88 
N-ANS 53.40 0.7 54.05 0.79 
ANS-Me 69.55 1.29 70.29 1.37 
Ar-Go 45.58 0.91 48.05 1.09 
Ar-Go-Me 128.18 0.8 128.14 1.26 
Co-A 91.47 0.87 91.14 1.14 
Co-Gn 126.65 1.25 124.70 1.25 
Go-Gn 82.47 0.95 78.87 1.25 
 
 25 
Table 4.  P values Associated with the Variance Component General Linear Model.  
Variables             
. 
P-value for 
TDO 
P-value for 
Age 
P-value for 
Gender 
P-value for 
Edent 
SNA <0.001* 0.3 0.01 0.24 
SNB 0.1986 0.19 0.01 0.63 
ANB 0.002* 0.77 0.2 0.13 
N-Ba 0.11 0.02 <0.001 0.50 
S-N 0.32 0.01 <0.001 0.60 
S-Ba 0.28 0.38 <0.001 0.84 
Ba-S-N 0.58 0.97 0.01 0.19 
N-Me 0.69 <0.001 <0.001 0.18 
N-ANS 0.8 <0.001 <0.001 0.61 
ANS-Me 0.93 0.01 0.01 0.36 
Ar-Go 0.05* <0.001 <0.001 0.89 
Ar-Go-Me 0.87 0.99 0.22 0.78 
Co-A 0.76 0.02 <0.001 0.87 
Co-Gn 0.07 <0.001 <0.001 0.87 
Go-Gn 0.01* 0.01 <0.001 0.85 
  
Table 4.  P values for cephalometric variables with the variance component general linear 
model.  Adjusting for age, gender and edentulous status, TDO status significantly affected 
SNA, ANB, ArGo and GoGn. 
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VIII. FIGURES 
 
Figure 1.  Representative Cephalometric Tracing 
 
S (Sella)
Ba (Basion)
Go (Gonion)
Me (Menton)
Po (Pogonion)
B (B point)
A (A point)
ANSPNS
N (Nasion)
Po (Porion)
Ob (Orbitale)
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Figure 2  Superimposition of Composite Tracings for TDO Affected and Unaffected 
 
 
Figure 2.  Superimposition of composite tracings generated from 53 TDO affected (red) and 
34 unaffected family members (black).  Superimpositions were performed along the Sella-
Nasion (S-N) line with registration at Sella (s) and the inferior border of the mandible with 
registration on Menton (Me). 
TDO affected 
Unaffected 
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